Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: November 4, 2009
Event: The Company announced a public offering of notes pursuant to an underwriting agreement dated November 4, 2009.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels. The document focuses exclusively on the execution of a new debt offering.
Material Changes
- Capital Structure: The Company is increasing its debt load through the issuance of new notes in a public offering.
- Legal Documentation: A Second Supplemental Indenture is being executed with Wells Fargo Bank, National Association, as trustee.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) regarding the sale of notes but does not include the text of that release or specific management commentary on future outlook within this document.
Risks and Contingencies: The filing does not explicitly detail risks or contingencies beyond the standard execution of the debt offering. The validity of the notes is supported by an opinion from Morgan, Lewis & Bockius LLP.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific amount, interest rate, and maturity of the notes being issued.
- Examine Exhibit 1.1 (Underwriting Agreement) for details on underwriting fees and conditions of the sale.
- Check Exhibit 4.1 (Second Supplemental Indenture) for covenants and terms governing the new debt.
- Verify the impact of this new debt issuance on the Company's total leverage ratios in subsequent quarterly filings (10-Q or 10-K).